
Startups


How Qualified Small Businesses Can Apply $500,000 a Year of R&D Credit to Payroll Tax
A qualified small business can apply up to $500,000 a year of its research credit to payroll tax. Here are the tests, the election steps and the filing rules.

How Form D's 15-Day Deadline Runs From a Startup's First Sale, With No SEC Fee
Form D is due 15 calendar days after a startup's first sale, with no SEC fee, while many states add their own notice filings and fees.

Kalshi's $40 Billion Series G Prices About 82% Above May's $22 Billion Series F
Kalshi said on 29 October it announced a $1 billion Series G at a $40 billion valuation, co-led by Wellington and Sequoia, up about 82% from May.

What Franchisors Must Disclose in 23 Items, and the 14-Day Minimum Before Signing
The federal Franchise Rule sets 23 disclosure items and a 14-day minimum between delivery and signing. Here is what each part does for a franchisee.

What a $1.5 Billion Series E at $6.2 Billion Means for Tenstorrent After Sale Talks
AI chip startup Tenstorrent, led by Jim Keller, announced a $1.5 billion Series E at a $6.2 billion valuation on 19 October 2026.

Modal raises $750 million Series D at $15.75 billion valuation
Accel led the $750 million round, with Kleiner Perkins joining, as the company said its annualized run rate had passed $1 billion and its valuation reached $15.75 billion.

A 409A appraisal dated within 12 months is presumed reasonable, absent a material event
A 409A valuation supports the strike price for startup options.

Multiply Labs raises $75 million Series B led by NantWorks
Multiply Labs said on October 6, 2026 that NantWorks leads its $75 million Series B. New investors include AstraZeneca and Teradyne, but no valuation was disclosed.

What your cap table tells an investor in the first 30 seconds
Before anyone reads your deck closely, the ownership spreadsheet has already answered the questions that matter. Here is what they are and how to fix the wrong answers.

The real cost of incorporating your startup in the wrong place
Where and how you form your company decides who can invest, what you owe each year and what it costs to undo later.

Founder vesting and the 83(b) election: the 30-day deadline explained
Why founders put vesting on their own shares, what the 83(b) election changes about the tax bill, and the filing window that cannot be fixed once it closes.

SAFE or convertible note: what you are actually agreeing to
Both instruments postpone the valuation argument, but they treat time, debt and dilution very differently. How each one works and the clauses to read twice.

What actually happens at your first priced round, step by step
From the term sheet to the wire, a priced round converts old instruments, resizes the option pool and rewrites your charter. Here is the sequence and the traps.

How a venture capital fund works, and why it changes who it backs
Fees, carry, fund life and the math of returning a fund explain most investor behavior that founders find puzzling. A plain guide to the machine behind the check.

The term sheet clauses that matter more than your valuation
Liquidation preferences, anti-dilution, board seats and protective provisions decide who gets paid and who decides. What each clause does, and what diligence follows.

